Bridgewater-based Amneal Pharmaceuticals has donated $2 million to multiple patient assistance foundations supporting individuals living with Parkinson’s disease in recognition of Parkinson’s Awareness Month.
Amneal’s donations will support programs that help eligible patients manage out-of-pocket costs, including copayments, coinsurance, and deductibles for FDA-approved Parkinson’s medications.
These contributions reflect Amneal’s ongoing commitment to expanding access to essential medicines and supporting patient care, education, and advocacy for the Parkinson’s community.
During the past two years, Amneal has donated $3.5 million to support patients living with Parkinson’s disease.
Amneal will also continue to support those in need by participating in advocacy events nationwide and offering educational resources, including materials for Spanish-speaking audiences.
Every six minutes, someone in the US is diagnosed with Parkinson’s disease, a condition that affects more than 10 million people worldwide.
